Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
November 6, 2024 News by Marisa Wexler, MS. Scientists create platform for devices that wrap around nerve fibers. A new technology is designed to be a “wearable” device for neurons, wrapping ...
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · The Phase 2 FENopta trial (NCT05119569) evaluated fenebrutinib’s safety and efficacy in 109 adults, ages 18-55, with relapsing forms of MS, including relapsing-remitting MS and active secondary ...
MRI analysis of MS ReBUILD data shows remyelination with...
Jun 16, 2023 · October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. March 6, 2024 News by Marisa Wexler, MS.
MS prognosis and life expectancy - Multiple Sclerosis News Today
Feb 13, 2024 · But when most patients received treatment, only about 10% converted to SPMS, and over a median of 32 years. In approximately 15% of MS patients, the disease will enter a progressive phase ...
Treatment of progressive MS hits milestones in recent years: Study
August 14, 2024 News by Esteban Domínguez Cerezo, MS. Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS. July 12, 2024 News by Katherine Poinsatte, PhD.
Cholesterol medications might be able to be repurposed for MS
Oct 25, 2024 · January 11, 2023 News by Marisa Wexler, MS. Neural Stem Cell Therapy for MS Tolerated Well in Small Phase 1 Study. Subscribe to our newsletter. Get regular updates to your inbox.
MS news notes: Diagnosing PPMS, NB-4746, Neubie stimulation
Sep 5, 2023 · The story looks at a study in the Netherlands that reviewed data from 322 people diagnosed with PPMS between 1974 and 2019. The researchers found that only 228 of them actually met the criteria ...
MS news notes: Stem cell therapy, genetic variant, diet
Jul 3, 2023 · The MS News Today article “ Stem cell therapy highly effective in active RRMS: Real-world study ” reports that nearly 80% of participants with highly active relapsing-remitting multiple ...
MS news notes: Stem cell therapy, early Aubagio use, DMTs
May 1, 2023 · Several years ago, MS News Today reported that researchers disagreed at the time about whether to start any treatment for people with RIS. New data from a Phase 3 clinical trial show that 28 of ...
MS news notes: Measuring the cost of MS, early treatment, Pilates
Aug 21, 2023 · MS is costly to patients and society. People with MS understand how costly the disease can be in terms of treatments, insurance, quality of life, and other factors.But the MS News Today story ...